Although ICSI has meant a significant advance in the field of reproductive medicine in patients with male infertility problems, there is a certain disparity of opinions in the medical world about its use in other cases of infertility.
The study, led by the biologist Dr Elisabet Clua, head of the Oocyte and Embryo Donation Programme at Dexeus Mujer, was carried out at this centre between April 2017 and August 2018. The sample of women under study were recipients…
Dr Mª Angela Pascual, head of R&D&I at the Gynaecological Diagnostic Imaging Service of Dexeus Mujer, has participated in a large prospective multicentre European study performed in pre- and post-menopausal women in order to describe the ultrasound findings…
In the last two decades, C-section rates have risen from 15 to 25% in the public healthcare system, and from 28 to 38% in the private sector. The causes of this increase are many and, often, unclear. For this reason, Dexeus Mujer has participated in a retrospective study…
A team of researchers at Dexeus Mujer has carried out a study, led by Dr Máximo Izquierdo, which analyses the relationship between bone mineral density (BMD) and breast cancer in postmenopausal women. The study was carried out on a sample of 340…
Carme Pons, a clinical embryologist at Dexeus Mujer and a member of the Embryology Interest Group of the Spanish Association for the Study of Reproductive Biology (ASEBIR), has led a multicentre study promoted by this interest group.
Although ICSI has meant a significant advance in the field of reproductive medicine in patients with male infertility problems, there is a certain disparity of opinions in the medical world about its use in other cases of infertility.
The study, led by the biologist Dr Elisabet Clua, head of the Oocyte and Embryo Donation Programme at Dexeus Mujer, was carried out at this centre between April 2017 and August 2018. The sample of women under study were recipients…
Dr Mª Angela Pascual, head of R&D&I at the Gynaecological Diagnostic Imaging Service of Dexeus Mujer, has participated in a large prospective multicentre European study performed in pre- and post-menopausal women in order to describe the ultrasound findings…
In the last two decades, C-section rates have risen from 15 to 25% in the public healthcare system, and from 28 to 38% in the private sector. The causes of this increase are many and, often, unclear. For this reason, Dexeus Mujer has participated in a retrospective study…
A team of researchers at Dexeus Mujer has carried out a study, led by Dr Máximo Izquierdo, which analyses the relationship between bone mineral density (BMD) and breast cancer in postmenopausal women. The study was carried out on a sample of 340…
Carme Pons, a clinical embryologist at Dexeus Mujer and a member of the Embryology Interest Group of the Spanish Association for the Study of Reproductive Biology (ASEBIR), has led a multicentre study promoted by this interest group.
At Dexeus Mujer, two techniques are routinely applied to maintain haemostasis: temporary clipping of both uterine arteries at their origin and of the ovarian vessels at the pelvic infundibulum, and intramyometrial epinephrine injection before performing the hysterectomy.
The variables analysed were: current age, age at onset of menopause, smoking, habits, handgrip strength, body mass index, and adiposity assessed by bioelectrical impedance. Physical activity levels were assessed by means the International Physical Activity Questionnaire.
A total of 1,495 cryotransfer cycles with Preimplantation Genetic Testing (PGT) performed between August 2017 and December 2019 analysed. All patients were between 18 and 40 years old and had previously undergone an ovarian stimulation treatment.
The fact that women with hyperandrogenism present an increased number of antral follicles suggests a role of androgens in follicular development. Clinical examples of this effect are polycystic ovary syndrome (PCOS) and patients with congenital adrenal hyperplasia…
DEXEUS CAMPUS
Gran Vía de Carles III 71-75
08028 Barcelona
campus@dexeus.com
(+34) 93 227 47 09
